Paper404701
Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
Hoiby N and 5 others. Scand J Respir Dis, 1977. Cited by 222 papers, by iCite.
Cite this record
ConductScience Library. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Papers, record 404701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/404701
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Pseudomonas Infections | Major topic |
| Respiratory Tract Infections | Major topic |
| Antibodies, Bacterial | |
| Chronic Disease | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Immunoelectrophoresis, Two-Dimensional | |
| Male | |
| Precipitin Tests | |
| Prognosis | |
| Pseudomonas aeruginosa | |
| Respiratory Function Tests | |
| Sputum |
Source PubMed
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 222 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41597528 | Planktonic Aggregation Enhances Antibiotic Tolerance in Non-MDR Acinetobacter baumannii. | Microorganisms | 2025 | https://conductscience.org/library/papers/41597528 | PubMed |
| 41324029 | A comprehensive study on the dual species biofilm formation of clinical Staphylococcus aureus and Candida albicans strains from the same origins. | Biofilm | 2025 | https://conductscience.org/library/papers/41324029 | PubMed |
| 40636524 | Combined Forces Against Bacteria: Phages and Antibiotics. | Health Sci Rep | 2025 | https://conductscience.org/library/papers/40636524 | PubMed |
| 40506442 | Immune system dynamics in response to Pseudomonas aeruginosa biofilms. | NPJ Biofilms Microbiomes | 2025 | https://conductscience.org/library/papers/40506442 | PubMed |
| 40298413 | Antibody-guided identification of Achromobacter xylosoxidans protein antigens in cystic fibrosis. | mSphere | 2025 | https://conductscience.org/library/papers/40298413 | PubMed |
| 39811797 | Cystic fibrosis and the clinical biofilm revolution A survey of the Danish CF Center's contribution. | Biofilm | 2025 | https://conductscience.org/library/papers/39811797 | PubMed |
| 39015565 | Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response. | Front Immunol | 2024 | https://conductscience.org/library/papers/39015565 | PubMed |
| 38863450 | Staphylococcal mastitis in dairy cows. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/38863450 | PubMed |
| 37943284 | Eco-evolutionary dynamics of experimental Pseudomonas aeruginosa populations under oxidative stress. | Microbiology (Reading) | 2023 | https://conductscience.org/library/papers/37943284 | PubMed |
| 37658117 | The non-attached biofilm aggregate. | Commun Biol | 2023 | https://conductscience.org/library/papers/37658117 | PubMed |
| 36417800 | Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway. | Tuberculosis (Edinb) | 2023 | https://conductscience.org/library/papers/36417800 | PubMed |
| 36140163 | Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140163 | PubMed |
| 36069898 | Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung. | J Pediatric Infect Dis Soc | 2022 | https://conductscience.org/library/papers/36069898 | PubMed |
| 36038584 | Microbiome-derived antimicrobial peptides offer therapeutic solutions for the treatment of Pseudomonas aeruginosa infections. | NPJ Biofilms Microbiomes | 2022 | https://conductscience.org/library/papers/36038584 | PubMed |
| 35863022 | Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35863022 | PubMed |
| 34222225 | Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34222225 | PubMed |
| 34054785 | Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34054785 | PubMed |
| 33937932 | NO donors and NO delivery methods for controlling biofilms in chronic lung infections. | Appl Microbiol Biotechnol | 2021 | https://conductscience.org/library/papers/33937932 | PubMed |
| 33717034 | Peptidoglycan-Binding Anchor Is a Pseudomonas aeruginosa OmpA Family Lipoprotein With Importance for Outer Membrane Vesicles, Biofilms, and the Periplasmic Shape. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33717034 | PubMed |
| 33692800 | Immune Responses to Pseudomonas aeruginosa Biofilm Infections. | Front Immunol | 2021 | https://conductscience.org/library/papers/33692800 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/404701
GET https://conductscience.org/api/papers/v1/404701/cited_by?page=2